Non-myeloablative conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia. The impact of the remission status

Multicentre randomized trials have shown that allogeneic hematopoietic stem cell transplantation (HSCT) is the most effective strategy for preventing relapse in patients in first complete remission (CR) of acute myeloblastic leukemia (AML), offering up to 50% disease-free survival. However in adult...

Descripción completa

Detalles Bibliográficos
Autores principales: Gutiérrez Aguirre, César Homero, Cantú Rodríguez, Olga Graciela, González Llano, Óscar, Salazar Riojas, R., Martínez González, Odra Lizzette, Jaime Pérez, José Carlos, Gómez Almaguer, David
Formato: Artículo
Lenguaje:inglés
Publicado: 2005
Materias:
Acceso en línea:http://eprints.uanl.mx/27802/1/492.pdf
_version_ 1824420827097989120
author Gutiérrez Aguirre, César Homero
Cantú Rodríguez, Olga Graciela
González Llano, Óscar
Salazar Riojas, R.
Martínez González, Odra Lizzette
Jaime Pérez, José Carlos
Gómez Almaguer, David
author_facet Gutiérrez Aguirre, César Homero
Cantú Rodríguez, Olga Graciela
González Llano, Óscar
Salazar Riojas, R.
Martínez González, Odra Lizzette
Jaime Pérez, José Carlos
Gómez Almaguer, David
author_sort Gutiérrez Aguirre, César Homero
collection Repositorio Institucional
description Multicentre randomized trials have shown that allogeneic hematopoietic stem cell transplantation (HSCT) is the most effective strategy for preventing relapse in patients in first complete remission (CR) of acute myeloblastic leukemia (AML), offering up to 50% disease-free survival. However in adult patients with good risk AML, allogeneic HSCT is usually indicated in second complete remission or first untreated relapse. We analyzed the outcome of 16 AML patients who received a reduced intensity conditioning regimen for allogeneic HSCT in first or second remission.
format Article
id eprints-27802
institution UANL
language English
publishDate 2005
record_format eprints
spelling eprints-278022024-12-09T17:50:40Z http://eprints.uanl.mx/27802/ Non-myeloablative conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia. The impact of the remission status Gutiérrez Aguirre, César Homero Cantú Rodríguez, Olga Graciela González Llano, Óscar Salazar Riojas, R. Martínez González, Odra Lizzette Jaime Pérez, José Carlos Gómez Almaguer, David RD Cirugía Multicentre randomized trials have shown that allogeneic hematopoietic stem cell transplantation (HSCT) is the most effective strategy for preventing relapse in patients in first complete remission (CR) of acute myeloblastic leukemia (AML), offering up to 50% disease-free survival. However in adult patients with good risk AML, allogeneic HSCT is usually indicated in second complete remission or first untreated relapse. We analyzed the outcome of 16 AML patients who received a reduced intensity conditioning regimen for allogeneic HSCT in first or second remission. 2005 Article PeerReviewed text en http://eprints.uanl.mx/27802/1/492.pdf http://eprints.uanl.mx/27802/1.haspreviewThumbnailVersion/492.pdf Gutiérrez Aguirre, César Homero y Cantú Rodríguez, Olga Graciela y González Llano, Óscar y Salazar Riojas, R. y Martínez González, Odra Lizzette y Jaime Pérez, José Carlos y Gómez Almaguer, David (2005) Non-myeloablative conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia. The impact of the remission status. Biology of Blood and Marrow Transplantation, 11 (2). pp. 61-62. ISSN 10838791 http://doi.org/10.1016/j.bbmt.2004.12.184 doi:10.1016/j.bbmt.2004.12.184
spellingShingle RD Cirugía
Gutiérrez Aguirre, César Homero
Cantú Rodríguez, Olga Graciela
González Llano, Óscar
Salazar Riojas, R.
Martínez González, Odra Lizzette
Jaime Pérez, José Carlos
Gómez Almaguer, David
Non-myeloablative conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia. The impact of the remission status
thumbnail https://rediab.uanl.mx/themes/sandal5/images/online.png
title Non-myeloablative conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia. The impact of the remission status
title_full Non-myeloablative conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia. The impact of the remission status
title_fullStr Non-myeloablative conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia. The impact of the remission status
title_full_unstemmed Non-myeloablative conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia. The impact of the remission status
title_short Non-myeloablative conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia. The impact of the remission status
title_sort non myeloablative conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia the impact of the remission status
topic RD Cirugía
url http://eprints.uanl.mx/27802/1/492.pdf
work_keys_str_mv AT gutierrezaguirrecesarhomero nonmyeloablativeconditioningforallogeneichematopoieticstemcelltransplantationinpatientswithacutemyeloidleukemiatheimpactoftheremissionstatus
AT canturodriguezolgagraciela nonmyeloablativeconditioningforallogeneichematopoieticstemcelltransplantationinpatientswithacutemyeloidleukemiatheimpactoftheremissionstatus
AT gonzalezllanooscar nonmyeloablativeconditioningforallogeneichematopoieticstemcelltransplantationinpatientswithacutemyeloidleukemiatheimpactoftheremissionstatus
AT salazarriojasr nonmyeloablativeconditioningforallogeneichematopoieticstemcelltransplantationinpatientswithacutemyeloidleukemiatheimpactoftheremissionstatus
AT martinezgonzalezodralizzette nonmyeloablativeconditioningforallogeneichematopoieticstemcelltransplantationinpatientswithacutemyeloidleukemiatheimpactoftheremissionstatus
AT jaimeperezjosecarlos nonmyeloablativeconditioningforallogeneichematopoieticstemcelltransplantationinpatientswithacutemyeloidleukemiatheimpactoftheremissionstatus
AT gomezalmaguerdavid nonmyeloablativeconditioningforallogeneichematopoieticstemcelltransplantationinpatientswithacutemyeloidleukemiatheimpactoftheremissionstatus